New drug duo aims to shrink aggressive breast cancer before surgery
Disease control
Not yet recruiting
This phase 2 trial tests a combination of two drugs—sacituzumab tirumotecan and pembrolizumab—given before surgery to people with stage II or III triple-negative breast cancer. The goal is to see if the treatment can completely eliminate the cancer by the time of surgery. The stu…
Phase: PHASE2 • Sponsor: Yantai Yuhuangding Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC